AKBA Akebia Therapeutics
$0.74
Akebia Therapeutics (AKBA) Earnings News
Earnings press releases, previews and reviews for Akebia Therapeutics (AKBA), newest first. Our most recent is preview: Akebia's Vafseo Ramp Faces Its First Post-VOICE Test as Auryxia Erosion Drags the Top Line.
Thursday
October 29, 2026
11:51 AM ET
Akebia's Vafseo Ramp Faces Its First Post-VOICE Test as Auryxia Erosion Drags the Top Line
Earnings Whispers · Preview
Thursday
October 29, 2026
8:00 AM ET
Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights
Wednesday
August 5, 2026
4:05 PM ET
Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Wednesday
July 29, 2026
8:00 AM ET
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
Thursday
May 7, 2026
7:00 AM ET
Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights